Betting big on Gamma Delta T Cells
Until recently, Gamma Delta T Cells, which live in our tissue and form a crucial part of our immune system,…
All articles by Molly Lempriere
Molly Lempriere
-
-
Reforming paediatric cancer trials in Europe
Cancer experts are calling on European officials to reform outdated rules on clinical trials that allow pharmaceutical companies to opt…
-
Could a temperature-resistant vaccine spell the end for rabies and yellow fever?
Rabies and yellow fever claim tens of thousands of lives every year and although vaccines do exist, they are either…
-
Cancergraph: a desperately needed link between patient and clinical trial
Clinical trial recruitment can be notoriously challenging. For the pharma company, it can be tough to find patients that meet…
-
Medicines Discovery Catapult: improving collaborative drug discovery in the UK
Drug discovery is a notoriously expensive and time-consuming process, with many potential stumbling blocks on the path from research lab…
-
Why the UK NHS needs clinical research
In October last year, the National Institute for Health Research (NIHR) made a welcome announcement – for the first time,…
-
Pay-for-delay: how far will companies go to protect market exclusivity?
Pay-for-delay agreements, or reverse payment patent settlements, have been under scrutiny for a while. In essence, these deals allow large…
-
Genomic array could unlock war against diseases in Africa
A new cost-effective array designed specifically to study African populations will offer researchers unprecedented insight into the genomic and environmental…
-
Developing new drugs for Tourette syndrome
Despite being a relatively common condition, Tourette syndrome (TS) is widely misunderstood. Affecting as many as one in every one…